Pharma giant Bristol-Myers Squibb just made another big bet on cancer immunotherapy – Business Insider
Business Insider |
Pharma giant Bristol-Myers Squibb just made another big bet on cancer immunotherapy
Business Insider Bristol-Myers has two drugs, Opdivo and Yervoy, that are a part of a new class of cancer treatments called cancer immunotherapy that harness the body's immune system to go after cancer. Unlike chemotherapy, which involves administering powerful drugs … IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout |
